10 research outputs found
Use of tunneled pleural catheters in chronic empyema: Two case reports and brief review of the literature
The incidence of empyema is increasing worldwide, which, coupled with the aging global population, makes the non-surgical management of pleural space infections increasingly important. Despite this, there remains no consensus for management of chronic empyema in those patients who are not surgical candidates and do not get adequate source control with chest tube and intra-pleural lytic therapy, particularly for patients with non-expandable lungs. We reviewed the literature regarding non-surgical management of chronic empyema and present two cases that support the use of pleuroscopy in conjunction with tunneled pleural catheters for management of chronic empyema in non-surgical candidates
Recommended from our members
Use of tunneled pleural catheters in chronic empyema: Two case reports and brief review of the literature
The incidence of empyema is increasing worldwide, which, coupled with the aging global population, makes the non-surgical management of pleural space infections increasingly important. Despite this, there remains no consensus for management of chronic empyema in those patients who are not surgical candidates and do not get adequate source control with chest tube and intra-pleural lytic therapy, particularly for patients with non-expandable lungs. We reviewed the literature regarding non-surgical management of chronic empyema and present two cases that support the use of pleuroscopy in conjunction with tunneled pleural catheters for management of chronic empyema in non-surgical candidates
Recommended from our members
Medical Societies Must Choose Professional Meeting Locations Responsibly in a Post-Roe World
Key highlights From the American association for bronchology and interventional pulmonology evidence-informed guidelines and expert panel report for the management of indwelling pleural catheters
Malignant pleural effusions (MPEs) are associated with reduced survival and contribute to significant morbidity and burden on the health-care system. Although there are numerous MPE management strategies, such as pleurodesis and intermittent drainage via thoracentesis, indwelling pleural catheters (IPCs) have become an effective tool in both managing symptoms and reducing the need for hospitalization in the end-stages of life. The American Association for Bronchology and Interventional Pulmonology (AABIP) recently had society-endorsed guidelines “AABIP Evidence-Informed Guidelines and Expert Panel Report for the Management of Indwelling Pleural Catheters”1 published in the Journal of Bronchology and Interventional Pulmonology to address issues relevant to the postinsertion management of IPCs in MPEs.1 This commentary summarizes many of the key recommendations from the guidelines in a frequently-asked-questions format
AABIP evidence-informed guidelines and expert panel report for the management of indwelling pleural catheters
BACKGROUND: While the efficacy of Indwelling pleural catheters for palliation of malignant pleural effusions is supported by relatively robust evidence, there is less clarity surrounding the postinsertion management. METHODS: The Trustworthy Consensus-Based Statement approach was utilized to develop unbiased, scientifically valid guidance for the management of patients with malignant effusions treated with indwelling pleural catheters. A comprehensive electronic database search of PubMed was performed based on a priori crafted PICO questions (Population/Intervention/Comparator/Outcomes paradigm). Manual searches of the literature were performed to identify additional relevant literature. Dual screenings at the title, abstract, and full-text levels were performed. Identified studies were then assessed for quality based on a combination of validated tools. Appropriateness for data pooling and formation of evidence-based recommendations was assessed using predetermined criteria. All panel members participated in development of the final recommendations utilizing the modified Delphi technique. RESULTS: A total of 7 studies were identified for formal quality assessment, all of which were deemed to have a high risk of bias. There was insufficient evidence to allow for data pooling and formation of any evidence-based recommendations. Panel consensus resulted in 11 ungraded consensus-based recommendations. CONCLUSION: This manuscript was developed to provide clinicians with guidance on the management of patients with indwelling pleural catheters placed for palliation of malignant pleural effusions. Through a systematic and rigorous process, management suggestions were developed based on the best available evidence with augmentation by expert opinion when necessary. In addition, these guidelines highlight important gaps in knowledge which require further study
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution
The human bronchial epithelium is composed of multiple distinct cell types that cooperate to defend against environmental insults. While studies have shown that smoking alters bronchial epithelial function and morphology, its precise effects on specific cell types and overall tissue composition are unclear. We used single-cell RNA sequencing to profile bronchial epithelial cells from six never and six current smokers. Unsupervised analyses led to the characterization of a set of toxin metabolism genes that localized to smoker ciliated cells, tissue remodeling associated with a loss of club cells and extensive goblet cell hyperplasia, and a previously unidentified peri-goblet epithelial subpopulation in smokers who expressed a marker of bronchial premalignant lesions. Our data demonstrate that smoke exposure drives a complex landscape of cellular alterations that may prime the human bronchial epithelium for disease